These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
725 related articles for article (PubMed ID: 24125749)
21. Targeting Wnt signaling: can we safely eradicate cancer stem cells? Takahashi-Yanaga F; Kahn M Clin Cancer Res; 2010 Jun; 16(12):3153-62. PubMed ID: 20530697 [TBL] [Abstract][Full Text] [Related]
22. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model. Boerboom D; White LD; Dalle S; Courty J; Richards JS Cancer Res; 2006 Feb; 66(4):1964-73. PubMed ID: 16488995 [TBL] [Abstract][Full Text] [Related]
23. [Identification of Wnt/beta-catenin signal pathway in human prostate cancer cell lines and its significance]. Jiang YG; Zhao JH; Luo Y; He DL; Wang XY; Cui XH Zhonghua Nan Ke Xue; 2009 Apr; 15(4):310-3. PubMed ID: 19472902 [TBL] [Abstract][Full Text] [Related]
24. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704 [TBL] [Abstract][Full Text] [Related]
25. Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development. Boerboom D; Paquet M; Hsieh M; Liu J; Jamin SP; Behringer RR; Sirois J; Taketo MM; Richards JS Cancer Res; 2005 Oct; 65(20):9206-15. PubMed ID: 16230381 [TBL] [Abstract][Full Text] [Related]
26. Identification of genes regulated by Wnt/beta-catenin pathway and involved in apoptosis via microarray analysis. Huang M; Wang Y; Sun D; Zhu H; Yin Y; Zhang W; Yang S; Quan L; Bai J; Wang S; Chen Q; Li S; Xu N BMC Cancer; 2006 Sep; 6():221. PubMed ID: 16959035 [TBL] [Abstract][Full Text] [Related]
27. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Fodde R; Brabletz T Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971 [TBL] [Abstract][Full Text] [Related]
28. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis. Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281 [TBL] [Abstract][Full Text] [Related]
29. Beta-catenin in the race to fracture repair: in it to Wnt. Silkstone D; Hong H; Alman BA Nat Clin Pract Rheumatol; 2008 Aug; 4(8):413-9. PubMed ID: 18560386 [TBL] [Abstract][Full Text] [Related]
30. Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. Su HY; Lai HC; Lin YW; Liu CY; Chen CK; Chou YC; Lin SP; Lin WC; Lee HY; Yu MH Int J Cancer; 2010 Aug; 127(3):555-67. PubMed ID: 19957335 [TBL] [Abstract][Full Text] [Related]
31. The Wnt/beta-catenin pathway in adrenocortical development and cancer. El Wakil A; Lalli E Mol Cell Endocrinol; 2011 Jan; 332(1-2):32-7. PubMed ID: 21094679 [TBL] [Abstract][Full Text] [Related]
32. Wnt signaling as a therapeutic target for cancer. Herbst A; Kolligs FT Methods Mol Biol; 2007; 361():63-91. PubMed ID: 17172707 [TBL] [Abstract][Full Text] [Related]
33. Phospholipase D meets Wnt signaling: a new target for cancer therapy. Kang DW; Choi KY; Min do S Cancer Res; 2011 Jan; 71(2):293-7. PubMed ID: 21224347 [TBL] [Abstract][Full Text] [Related]
34. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286 [TBL] [Abstract][Full Text] [Related]
35. Role of the Wnt/beta-catenin network in regulating hematopoiesis. Wilusz M; Majka M Arch Immunol Ther Exp (Warsz); 2008; 56(4):257-66. PubMed ID: 18726147 [TBL] [Abstract][Full Text] [Related]
36. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476 [TBL] [Abstract][Full Text] [Related]
37. Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer. Ghahhari NM; Babashah S Eur J Cancer; 2015 Aug; 51(12):1638-49. PubMed ID: 26025765 [TBL] [Abstract][Full Text] [Related]
38. Elevated β-catenin activity contributes to carboplatin resistance in A2780cp ovarian cancer cells. Barghout SH; Zepeda N; Xu Z; Steed H; Lee CH; Fu Y Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):173-8. PubMed ID: 26522223 [TBL] [Abstract][Full Text] [Related]
39. Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer. Arend RC; Londoño-Joshi AI; Gangrade A; Katre AA; Kurpad C; Li Y; Samant RS; Li PK; Landen CN; Yang ES; Hidalgo B; Alvarez RD; Straughn JM; Forero A; Buchsbaum DJ Oncotarget; 2016 Dec; 7(52):86803-86815. PubMed ID: 27888804 [TBL] [Abstract][Full Text] [Related]
40. Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway. Li B; Cai S; Zhao Y; He Q; Yu X; Cheng L; Zhang Y; Hu X; Ke M; Chen S; Zou M Oncotarget; 2016 Dec; 7(49):81026-81048. PubMed ID: 27835587 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]